(Q44995061)

English

Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients

scientific article published on 22 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients (English)

1 reference

Europe PubMed Central

8 December 2017

0 references

1 reference

based on heuristic

inferred from title

Dirk J van Veldhuisen

6

object named as

Dirk J van Veldhuisen

1 reference

Europe PubMed Central

8 December 2017

Adriaan A Voors

7

object named as

Adriaan A Voors

1 reference

Europe PubMed Central

8 December 2017

author name string

Suzan Willemsen

1

1 reference

Europe PubMed Central

8 December 2017

Jasper W L Hartog

2

1 reference

Europe PubMed Central

8 December 2017

Yoran M Hummel

3

1 reference

Europe PubMed Central

8 December 2017

Marieke H I van Ruijven

4

1 reference

Europe PubMed Central

8 December 2017

Iwan C C van der Horst

5

1 reference

Europe PubMed Central

8 December 2017

publication date

22 September 2010

1 reference

Europe PubMed Central

8 December 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

8 December 2017

13

1 reference

Europe PubMed Central

8 December 2017

1

1 reference

Europe PubMed Central

8 December 2017

76-82

1 reference

Europe PubMed Central

8 December 2017

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Advanced glycation endproducts in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Exercise training does not improve myocardial diastolic tissue velocities in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Simple noninvasive measurement of skin autofluorescence

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Recommendations for the evaluation of left ventricular diastolic function by echocardiography

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Diastolic function measurements and diagnostic consequences: a comparison of pulsed wave- and color-coded tissue Doppler imaging

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Stress testing methodology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Diabetes mellitus and congestive heart failure. Further knowledge needed

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Systolic and diastolic heart failure in the community.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ168

21 January 2018

Identifiers

10.1093/EURJHF/HFQ168

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44995061&oldid=2060739078"